MétaCan
Menu
Back to cohort
Record W4414878091 · doi:10.1002/hsr2.71356

Letter to the Editor: Unlocking Better Keloid Treatment: Corticosteroid, 5‐Fluorouracil, and Hyaluronidase vs. Corticosteroid Alone—A Randomized Comparative Study

2025· letter· en· W4414878091 on OpenAlexaboutno aff
Asifa Zardari

Bibliographic record

VenueHealth Science Reports · 2025
Typeletter
Languageen
FieldMedicine
TopicDermatologic Treatments and Research
Canadian institutionsnot available
Fundersnot available
KeywordsTriamcinolone acetonideKeloidHyaluronidaseCorticosteroidPlaceboRandomized controlled trialConfoundingSample size determinationAffect (linguistics)

Abstract

fetched live from OpenAlex

I read the article titled “Unlocking Better Keloid Treatment: Corticosteroid, 5-Fluorouracil, and Hyaluronidase versus Corticosteroid Alone—A Randomized Comparative Study” by Ehsani et al. with great interest. The study by Ehsani et al. introduces an innovative approach for treating keloid scars through a triple-drug intralesional injection combining triamcinolone acetonide, 5-fluorouracil (5-FU), and hyaluronidase [1]. Their findings highlight superior outcomes in lesion height reduction, pliability, and Modified Vancouver Scar Scale (MVSS) scores compared to corticosteroid monotherapy. The biological rationale for adding hyaluronidase due to its potential to mitigate fibroblast proliferation and enhance drug spread adds depth to the study's clinical relevance. However, the inability to isolate hyaluronidase's independent effect due to the absence of a steroid + 5-FU comparison group needs further discussion. Methodologically, the trial presents several considerations, primarily due to its small sample size of sixteen participants (n = 16), which affects statistical power and generalizability. Although nonparametric tests were appropriately applied, the lack of reported effect sizes weakens the interpretability of the results [2]. Furthermore, the single-blinded design, with patients aware of their treatment group, introduces performance bias that may affect subjective measures such as pain and pruritus [3]. While there were positive trends in these outcomes, they did not reach statistical significance, likely due to both small sample size and potential placebo effects. Biological confounders also emerge in this trial. Including hyaluronidase seems logical due to its role in modulating interleukin-1 and remodeling tissue; however, its effect is hard to separate from the well-established effects of 5-FU and triamcinolone [4]. Furthermore, the authors detected better outcomes in color change, but differences in initial scar pigmentation between groups undermine this finding. Moreover, the short follow-up duration of 2 months is insufficient to assess the risk of keloid recurrence, which is a key consideration in evaluating any scar therapy [5]. To strengthen future research, larger multicenter trials with extended follow-up are needed. A multi-arm design isolating the effects of individual agents would provide greater clarity, while a double-blinded methodology could minimize bias and improve validity. Stratification by lesion site and prior treatment history may also yield more refined insights. Despite its limitations, this study offers an encouraging step toward reducing the burden of keloids and underscores the promise of hyaluronidase as a potentially transformative therapeutic agent. Asifa Zardari: writing – original draft, conceptualization, investigation, visualization, writing – review and editing. I would like to sincerely acknowledge Dr. Muhammad Umar from Khairpur Medical College, Khairpur Mirs, Pakistan Email: [email protected] for his continued support and mentorship throughout the preparation and publication of this article. Permission to include his name has been obtained. The author declares no conflicts of interest. The author has nothing to report.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Science and technology studies
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.176
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.000
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.051
GPT teacher head0.382
Teacher spread0.331 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueHealth Science ReportsSame topicDermatologic Treatments and ResearchFrench-language works237,207